Puma Biotechnology
PBYI
PBYI
99 hedge funds and large institutions have $101M invested in Puma Biotechnology in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.52% more ownership
Funds ownership: 61.7% → 64.22% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $158M → $101M (-$56.7M)
Holders
99
Holding in Top 10
1
Calls
$417K
Puts
$84K
Top Buyers
| 1 | +$6.37M | |
| 2 | +$1.62M | |
| 3 | +$1.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.11M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$937K |
Top Sellers
| 1 | -$8.74M | |
| 2 | -$1.35M | |
| 3 | -$958K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$905K |
| 5 |
Goldman Sachs
New York
|
-$815K |